PRDX1 and pancreatic neoplasm: Also, since silencing PRDX1 sensitized the pancreatic cancer cells to paclitaxel even in the presence of Pre-Q indicated that Q induced chemoresistance was being mediated via PRDX1 (Figure 6c).